Print
Why Smart Patients Are Now Refusing Vaccinated Blood
Few people ever imagine they will face a medical emergency requiring a blood transfusion. Yet when that moment comes, the assumption is simple: the blood will be safe. But what if it isn’t? For many families, the COVID-19 era raised new questions about whether blood donations could carry dangerous, unwanted risks.
During a pregnancy, one family discovered how complicated it was to secure blood from unvaccinated donors. They needed a special note from the doctor, cooperation from the blood bank, and the help of friends willing to donate. The blood could only be stored for a month, making timing crucial. The ordeal was exhausting, but it revealed a problem thousands of others have encountered: what happens when you don’t want transfusions from a donor who received mRNA injections?
This question has inspired the rise of a global organization called SafeBlood. Its mission is to give patients back their freedom of choice while exposing overlooked dangers in the medical system.
Introducing “SafeBlood”
SafeBlood was founded by Swiss naturopath George Della Pietra after European practitioners began looking at blood samples under microscopes in the early days of the vaccine rollout. They claimed to notice dramatic changes in the blood of those who had received the injections. Healthy, unvaccinated blood looked normal, while vaccinated blood appeared altered.
Within weeks, SafeBlood was born. The organization now operates in over 55 countries, pairing blood transfusion recipients with donors who have not received the mRNA vaccines. In the United States, SafeBlood has grown rapidly because, despite eroding freedoms, Americans still retain more medical choice than many other nations.
Dr. Clinton Ohlers, Vice President and U.S. Director of Media Relations for SafeBlood, brings academic and professional credibility to the movement. With a PhD from the University of Pennsylvania and teaching experience at institutions such as Cambridge, the University of Hong Kong, and Birmingham, he now devotes his work to helping patients regain control of their health decisions.
Why Patients Want the Choice
SafeBlood’s concerns aren’t limited to philosophical issues. Reports of harm following transfusions have been mounting. Families describe infants who received transfusions and later developed fatal clots. Others tell of patients suffering strokes or myocarditis shortly after receiving blood from vaccinated donors.
The fear is simple: if the vaccine altered the blood of the donor, could those changes be passed on to the recipient? Early morticians’ reports of unusual clots in the vaccinated raised alarms. More recent revelations have deepened the concern. Independent researchers have found DNA contamination in vaccine vials at levels far beyond allowable limits, suggesting that fragments of foreign DNA could be circulating in the bloodstreams of millions worldwide.
Equally troubling are studies showing that some individuals still produce the spike protein years after their last shot. For those who never took the vaccine—or for vulnerable infants with naïve immune systems—the thought of receiving this blood is unsettling.
The Battle for Directed Donations
One of the most practical solutions is directed donation. This allows a patient to arrange for blood from specific donors, such as family or friends, to be reserved for their use. In many U.S. states, this is still possible. But increasingly, hospitals are restricting the option.
According to Dr. Ohlers, states such as Washington, Oregon, Minnesota, Wisconsin, and Ohio have begun denying patients the right to choose directed donations. Families desperate to secure blood for surgery have been forced to travel across the country to find willing hospitals. For patients already in fragile health, this can be nearly impossible.
SafeBlood not only pairs patients and donors but also fights legislative battles to preserve the freedom of directed donation. Leaders argue that eliminating this choice is a direct violation of medical liberty and puts patients at unnecessary risk.
Lessons from the Past
Big Pharma and its mainstream media jackals dismiss these concerns as hysteria or conspiracy theories. But history provides sobering parallels. In the 1980s, when HIV was spreading silently through blood banks, officials repeatedly reassured the public that transfusions were safe. It took years—and thousands of deaths—before the system admitted the risk and implemented screening protocols.
Famous individuals like tennis star Arthur Ashe lost their lives to transfusion-related AIDS, while hemophiliacs faced devastating infection rates. At the time, critics who raised concerns were accused of spreading fear. Today, SafeBlood argues, the same pattern is repeating with mRNA vaccines.
How SafeBlood Works
For those seeking protection, SafeBlood offers membership. Members are paired with compatible, unvaccinated donors within their state when transfusions are needed. Where hospitals resist cooperation, the organization helps patients travel to states where their wishes are respected.
Membership fees—$50 for signup and $10 a month—support the infrastructure needed to maintain a network of safe donors. Families are encouraged to join even if they never need the service, since building the network now ensures availability for others in emergencies. In cases such as childbirth or surgery, members are also advised to consider autologous donation—donating their own blood in advance for later use.
The Medical Establishment Pushback
Not everyone welcomes SafeBlood’s efforts. Some doctors have reacted with hostility, accusing patients who request unvaccinated blood of fearmongering or even bigotry. Critics have compared the movement to racial segregation in blood donations.
Yet the demand persists, and nurses on the ground often quietly support patients’ decisions. SafeBlood’s leaders point out that the big blood banks could easily label blood according to donor vaccination status, but refuse to do so, citing outdated studies from decades ago. The organization insists the refusal is not about science but about protecting entrenched financial and institutional interests.
Broader Implications for Medicine
The controversy extends beyond transfusions. Blood-derived products—such as certain immunoglobulin treatments and even breast milk from vaccinated mothers—may carry similar risks. Researchers like Dr. James Thorpe, a prominent obstetrician, warn that pregnant women should be especially cautious. He encourages expectant mothers to store their own blood ahead of delivery to reduce dependence on anonymous donations.
Meanwhile, evidence continues to mount that the vaccine story is not finished. Reports of ongoing DNA fragments, persistent spike protein production, and unexplained injuries have shifted the conversation from short-term safety to long-term consequences. SafeBlood argues that the blood supply cannot be trusted until transparency and screening protocols catch up with reality.
A Call to Action
For families who have already navigated the nightmare of trying to secure unvaccinated blood, the need for SafeBlood is obvious. For others, it may seem like a precaution they hope never to need. Yet the organization insists that membership is about more than individual safety—it is about securing the future of the global blood supply.
As hospitals restrict freedom of choice, SafeBlood continues to fight legislative battles across multiple states. Volunteers testify before lawmakers, distribute educational resources, and help families plan ahead for emergencies.
“Your blood is the safest blood for you,” Dr. Ohlers explains. “But until the system acknowledges these risks, we have to build alternatives.”
Guarding Future Health and Freedom
The debate over blood transfusions and vaccine contamination is unlikely to disappear anytime soon. Just as with the tragedies of the AIDS-tainted blood supply decades ago, the truth may take years to surface. In the meantime, SafeBlood is offering patients a chance to act now rather than wait.
Emergencies are unpredictable. A car accident, a complicated delivery, or a sudden surgery can put anyone in need of blood. For those who want assurance that the blood entering their veins reflects their own convictions about health and safety, SafeBlood offers a solution.
In the end, the issue is not only about medicine but about freedom—the freedom to make informed choices about what enters one’s body. For families who have fought through the maze of hospital bureaucracy, that freedom is worth everything.
